Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Charge Delocalization and Vibronic Couplings in Quadrupolar Squaraine Dyes.
Timmer D, Zheng F, Gittinger M, Quenzel T, Lünemann DC, Winte K, Zhang Y, Madjet ME, Zablocki J, Lützen A, Zhong JH, De Sio A, Frauenheim T, Tretiak S, Lienau C. Timmer D, et al. Among authors: zablocki j. J Am Chem Soc. 2022 Oct 19;144(41):19150-19162. doi: 10.1021/jacs.2c08682. Epub 2022 Oct 7. J Am Chem Soc. 2022. PMID: 36206456
Plasmon-Enhanced Exciton Delocalization in Squaraine-Type Molecular Aggregates.
Quenzel T, Timmer D, Gittinger M, Zablocki J, Zheng F, Schiek M, Lützen A, Frauenheim T, Tretiak S, Silies M, Zhong JH, De Sio A, Lienau C. Quenzel T, et al. Among authors: zablocki j. ACS Nano. 2022 Mar 22;16(3):4693-4704. doi: 10.1021/acsnano.1c11398. Epub 2022 Feb 21. ACS Nano. 2022. PMID: 35188735
Polymorphic chiral squaraine crystallites in textured thin films.
Zablocki J, Arteaga O, Balzer F, Hertel D, Holstein JJ, Clever G, Anhäuser J, Puttreddy R, Rissanen K, Meerholz K, Lützen A, Schiek M. Zablocki J, et al. Chirality. 2020 May;32(5):619-631. doi: 10.1002/chir.23213. Epub 2020 Mar 10. Chirality. 2020. PMID: 32155676
Prognostic Implications of Immature Platelet Fraction at 5-Year Follow-up Among ACS Patients Treated With Dual Antiplatelet Therapy.
Gumiężna K, Baruś P, Sygitowicz G, Wiśniewska A, Bednarek A, Zabłocki J, Piasecki A, Klimczak-Tomaniak D, Kochman J, Grabowski M, Tomaniak M. Gumiężna K, et al. Among authors: zablocki j. J Cardiovasc Pharmacol Ther. 2024 Jan-Dec;29:10742484231202864. doi: 10.1177/10742484231202864. J Cardiovasc Pharmacol Ther. 2024. PMID: 38196286 Free article.
Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B.
Mackman RL, Mish M, Chin G, Perry JK, Appleby T, Aktoudianakis V, Metobo S, Pyun P, Niu C, Daffis S, Yu H, Zheng J, Villasenor AG, Zablocki J, Chamberlain J, Jin H, Lee G, Suekawa-Pirrone K, Santos R, Delaney WE 4th, Fletcher SP. Mackman RL, et al. Among authors: zablocki j. J Med Chem. 2020 Sep 24;63(18):10188-10203. doi: 10.1021/acs.jmedchem.0c00100. Epub 2020 Jun 3. J Med Chem. 2020. PMID: 32407112
Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®.
Taylor JG, Zipfel S, Ramey K, Vivian R, Schrier A, Karki KK, Katana A, Kato D, Kobayashi T, Martinez R, Sangi M, Siegel D, Tran CV, Yang ZY, Zablocki J, Yang CY, Wang Y, Wang K, Chan K, Barauskas O, Cheng G, Jin D, Schultz BE, Appleby T, Villaseñor AG, Link JO. Taylor JG, et al. Among authors: zablocki j. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2428-2436. doi: 10.1016/j.bmcl.2019.03.037. Epub 2019 Mar 26. Bioorg Med Chem Lett. 2019. PMID: 31133531
Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor.
Sperandio D, Aktoudianakis V, Babaoglu K, Chen X, Elbel K, Chin G, Corkey B, Du J, Jiang B, Kobayashi T, Mackman R, Martinez R, Yang H, Zablocki J, Kusam S, Jordan K, Webb H, Bates JG, Lad L, Mish M, Niedziela-Majka A, Metobo S, Sapre A, Hung M, Jin D, Fung W, Kan E, Eisenberg G, Larson N, Newby ZER, Lansdon E, Tay C, Neve RM, Shevick SL, Breckenridge DG. Sperandio D, et al. Among authors: zablocki j. Bioorg Med Chem. 2019 Feb 1;27(3):457-469. doi: 10.1016/j.bmc.2018.11.020. Epub 2018 Nov 15. Bioorg Med Chem. 2019. PMID: 30606676
Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).
Koltun DO, Parkhill EQ, Kalla R, Perry TD, Elzein E, Li X, Simonovich SP, Ziebenhaus C, Hansen TR, Marchand B, Hung WK, Lagpacan L, Hung M, Aoyama RG, Murray BP, Perry JK, Somoza JR, Villaseñor AG, Pagratis N, Zablocki JA. Koltun DO, et al. Among authors: zablocki ja. Bioorg Med Chem Lett. 2018 Feb 1;28(3):541-546. doi: 10.1016/j.bmcl.2017.10.040. Epub 2017 Oct 20. Bioorg Med Chem Lett. 2018. PMID: 29254643
170 results